OLMA · Olema Pharmaceuticals, Inc.
$11.58
-0.18 (-1.53%)
At close · Aug 5
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$985.28M
Shares
87.35M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-06-29 | 2,273,509 | 645,782 | 2,919,291 | 38.2% |
| 2026-06-22 | 3,623,932 | 2,557,062 | 6,180,994 | 40.2% |
| 2026-06-15 | 1,290,075 | 1,533,084 | 2,823,159 | 39.6% |
| 2026-06-08 | 2,262,154 | 1,278,668 | 3,540,822 | 45.6% |
| 2026-06-01 | 1,678,994 | 2,624,903 | 4,303,897 | 47.2% |
| 2026-05-25 | 1,109,879 | 773,725 | 1,883,604 | 39.1% |
| 2026-05-18 | 1,211,185 | 1,233,098 | 2,444,283 | 43.8% |
| 2026-05-11 | 1,271,985 | 2,329,907 | 3,601,892 | 47.5% |
| 2026-05-04 | 1,013,489 | 859,452 | 1,872,941 | 44.6% |
| 2026-04-27 | 997,277 | 464,752 | 1,462,029 | 37.7% |
| 2026-04-20 | 1,061,205 | 435,271 | 1,496,476 | 34.9% |
| 2026-04-13 | 916,081 | 418,898 | 1,334,979 | 36.1% |
| 2026-04-06 | 1,363,565 | 620,298 | 1,983,863 | 42.6% |
| 2026-03-30 | 1,232,369 | 482,623 | 1,714,992 | 39.2% |
| 2026-03-23 | 1,561,453 | 932,512 | 2,493,965 | 39.9% |
| 2026-03-16 | 2,455,337 | 3,457,117 | 5,912,454 | 39.4% |
| 2026-03-09 | 7,466,390 | 3,494,107 | 10,960,497 | 48.6% |
| 2026-03-02 | 1,975,287 | 742,930 | 2,718,217 | 44.5% |
| 2026-02-23 | 1,583,799 | 1,130,773 | 2,714,572 | 43.8% |
| 2026-02-16 | 1,501,026 | 571,282 | 2,072,308 | 43.8% |
| 2026-02-09 | 1,605,595 | 1,845,299 | 3,450,894 | 50.0% |
| 2026-02-02 | 2,709,054 | 2,009,819 | 4,718,873 | 52.0% |
| 2026-01-26 | 1,663,457 | 650,226 | 2,313,683 | 49.0% |
| 2026-01-19 | 1,008,653 | 649,160 | 1,657,813 | 44.5% |
| 2026-01-12 | 1,994,664 | 668,726 | 2,663,390 | 41.6% |
| 2026-01-05 | 2,301,112 | 1,625,713 | 3,926,825 | 47.7% |
| 2025-12-29 | 971,564 | 681,739 | 1,653,303 | 45.1% |
| 2025-12-22 | 1,698,981 | 928,687 | 2,627,668 | 46.2% |
| 2025-12-15 | 4,322,644 | 4,494,507 | 8,817,151 | 51.0% |
| 2025-12-08 | 4,718,172 | 5,107,425 | 9,825,597 | 50.4% |
| 2025-12-01 | 3,824,515 | 2,887,980 | 6,712,495 | 52.3% |
| 2025-11-24 | 3,458,400 | 3,561,338 | 7,019,738 | 48.8% |
| 2025-11-17 | 13,104,486 | 45,153,172 | 58,257,658 | 46.9% |
| 2025-11-10 | 914,443 | 1,053,593 | 1,968,036 | 39.7% |
| 2025-11-03 | 967,913 | 1,048,257 | 2,016,170 | 44.5% |
| 2025-10-27 | 963,272 | 1,659,107 | 2,622,379 | 49.0% |
| 2025-10-20 | 2,181,602 | 2,472,965 | 4,654,567 | 45.7% |
| 2025-10-13 | 1,491,016 | 1,378,545 | 2,869,561 | 38.7% |
| 2025-10-06 | 1,653,091 | 1,014,603 | 2,667,694 | 45.5% |
| 2025-09-29 | 1,644,003 | 1,917,325 | 3,561,328 | 47.9% |
| 2025-09-22 | 1,168,454 | 983,452 | 2,151,906 | 41.8% |
| 2025-09-15 | 812,114 | 1,686,657 | 2,498,771 | 44.4% |
| 2025-09-08 | 973,214 | 2,388,160 | 3,361,374 | 52.9% |
| 2025-09-01 | 1,336,308 | 4,595,415 | 5,931,723 | 58.6% |
| 2025-08-25 | 149,528 | 308,238 | 457,766 | 36.1% |
| 2025-08-18 | 245,193 | 482,261 | 727,454 | 37.6% |
| 2025-08-11 | 623,307 | 681,305 | 1,304,612 | 41.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
31 filings
31 filers
Visit website
Investor relations